H2L Flashcards

1
Q

involves testing the compound library (or a part of
it) to find out molecules that act on the desired target
(i.e. the hits)

A

HIT GENERATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Enforce attrition to immediately discard
anything that has no chance of being active

A

HIT GENERATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

make sure that the hits or other
compounds are more competitive; eliminate
compounds that are not competitive

A

Attrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Screening process here is STRICT

A

HIT GENERATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

rampant and
should be eliminated

A

Nuisance molecules

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Hits must be validated, otherwise they are
merely called

A

actives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Actives that look like they’re working but are not

A

FALSE POSITIVES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Positive result but the hit is not interacting with the
target

A

FALSE POSITIVES

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Common types of false positives:

A

Promiscuous binders
Pan-assay Interference Compounds
(PAINs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

actives that actually
bind the desired target, but target many other
things too

A

Promiscuous binders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Usually lead to unwanted toxicity or side
effects

A

Promiscuous binders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Entertain everything and tend to trigger
toxic effect

A

Promiscuous binders

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

actives that don’t bind to the desired
target at ALL

A

Pan-assay Interference Compounds
(PAINs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Just gives positive results to any assay
thrown at it

A

Pan-assay Interference Compounds
(PAINs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Interfere with different assay

A

Pan-assay Interference Compounds
(PAINs)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

It is a __________ if an active binds to an unwanted target, or does not bind to a real target.

A

red flag

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

-need to use primary and secondary screening
methods

A

HIT VALIDATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

use of counterscreens (secondary screening
method) which serve as a sort of trap

A

HIT VALIDATION

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

T/F: A REAL HIT MUST NOT PASS THE
COUNTERSCREEN

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Hits should test _________ in counterscreen

A

negative

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

If a test compound gives a positive
result for both the screen and
counterscreen, it is “_________” from
being a hit

A

disqualified

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

In Hit Validation, If hit disqualification does not give sufficient
confidence, the next resort is use of ____________

A

biophysical
techniques

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

A lead should

A

-have confirmed activity
-show evidence of desired selectivity
-have activity in cellular systems
-have stability in biologic systems
-Free from toxicity alerts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

T/F: Even if a true hit is potent, it may be toxic or have
poor ADME (pharmacokinetic profile)

A

T

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
assures that millions of dollars won’t be wasted developing a drug that will fail in clinical trials or be withdrawn from the market
Discharging risk ASAP
26
a ‘fail fast, fail cheap’ strategy
Discharging risk ASAP
27
Goal: Discharge risk as much and as early as possible
LEAD GENERATION
28
options in choosing the starting point
A: get existing drug B: New Drug/Indication
29
Researches can opt to use existing compounds in the human body
A: get existing drug
30
Use of existing molecules leads to _____________
me-too drugs
31
can often offer improvements over the original drug (‘me better’ drugs) as their selling point
me-too drugs
32
T/F: Me-too drugs can have challenges in drug registration by the FDA because the activity of the drug you are trying to register is the same as the one in the market,
T
33
Me-too drugs can have challenges in drug registration by the FDA because the activity of the drug you are trying to register is the same as the one in the market,
Serotonin
34
quaternary ammonium compound; template used to produce Cevemaline (dry mouth treatment)
Acetylcholine
35
derivative of Nebivolol (antihypertensive medication)
Norepinephrine
36
Drug is already developed but different activity is highlighted
OPTION B: NEW DRUG/INDICATION
37
Drug repurposing/repositioning SOSA
OPTION B: NEW DRUG/INDICATION
38
same drug, different activity
Drug repurposing/repositioning
39
same drug, but converted to an analogue, different activity
SOSA
40
modified drug molecule to further enhance the activity of the drug
Analogue
41
example of SOSA
Isoniazid
42
T/F: much time and money is saved when existing structures are used
T
43
Often follows forward approach to discovery
NATURAL
44
these are done to find actives, then followed by determination of mechanism of action and drug targets
Screens
45
Skips the need for getting many reagents and reacting them by organic synthesis
NATURAL
46
are very complex compounds, and thus, original most of the time
Natural products
47
Much more challenging than synthetic route in terms of compound isolation
NATURAL
48
Only limited number of unique compounds
NATURAL
49
“Back to Zero”
NATURAL
50
may be toxic
NATURAL
51
The Philippine drug discovery and development program
TUKLAS LUNAS
52
Employed in both forward and reverse approaches of discovery
synthetic compound libraries can be tested immediately
53
synthetic compound libraries can be tested immediately
forward method
54
libraries can be designed to obey predictive data that may come from previous CADD data
reverse method
55
Easier isolation, and skips the horrors of endless extraction and chromatography
synthetic
56
Can deliver up to thousands or millions of compounds
synthetic
57
Provides limited access to chemical space and requires more reaction steps
synthetic
58
produces mixtures of different compounds within each reaction vessel
Combinatorial synthesis
59
combinatorial synthesis is more random, and is more applicable for ________
hit-to-lead generation
60
produce a single product in each vessel
Parallel synthesis
61
More focused, and is more applicable for lead optimization
Parallel synthesis
62
Parallel and combinatorial methods are used not just for small molecule synthesis, but also
peptide synthesis
63
Both methods generally involve the use of
solid phase techniques
64
-A cross-linked insoluble polymeric support -An anchor or linker covalently linked to the resin -A bond linking the substrate to the linker -A means of cleaving
Essential requirements for solid phase synthesis:
65
The techniques of solid phase synthesis have been used to produce ______ quantities of compounds from a particular reaction sequence
large
66
Best to synthesize spider-like molecules than tadpole-like molecules
SYNTHETIC
67
Chances of success are greater if the “arms” are ____________ to allow more thorough exploration of chemical space
evenly spread
68
only explore chemical space on a limited area, and wastes the chance of seeing what can happen if other regions in space are filled
Tadpole-like molecules
69
Mixtures of compounds are produced in each vessel, allowing production of up to millions of novel structures in a span of time that only a few compounds are usually made with conventional labwork
COMBINATORIAL SYNTHESIS
70
In combinatorial synthesis, each reaction vessel is not purified, and is tested for biological activity as a ______
whole
71
Messy and expensive due to the need for many reagents
COMBINATORIAL SYNTHESIS
72
Can produce millions of structures
COMBINATORIAL SYNTHESIS
73
Sometimes called concentric synthesis
PARALLEL
74
Carried out in a series of wells such that each well contains a single product
PARALLEL
75
Reagents are added one by one without jumbling everything
PARALLEL
76
Lesser products made, but purer in quality
PARALLEL
77
Often used for lead optimization rather than generation
PARALLEL
78
NMR, XRC and SPR are used in this option
A: in vitro screening
79
Mistakes of HTS can be checked by _______ to ensure that the compounds concerned are binding in the correct binding site
NMR
80
Molecular recognition events are simulated and input as very large virtual compound libraries to be screened in silico
OPTION B: VIRTUAL SCREENING
81
Biological screening accounts for about 15% of the total expenditures of an industry
OPTION B: VIRTUAL SCREENING
82
if there is no information on activity yet
Prospective
83
if there are already known drugs
Retrospective
84
a classic method of testing thousands of compounds against the target, if the target protein is already well-known and has an existing X-ray structure
Molecular docking
85
with its intense computations, cannot be routinely done to thousands of compounds, and has to wait when leads are narrowed down during optimization
Molecular dynamics,
86
Pharmacophore models are useful especially when full elucidation of the drug target structure lags behind the results of screening experiments
OPTION B: VIRTUAL SCREENING (LBDD)
87
Once the pharmacophore model is constructed, ___________ can be done
virtual screening
88
no or little information is provided about the mechanism of action, BUT it does give direct results
HTS
89
not as convincing as HTS, but provides useful information about the mechanism of action
VS